{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:45:25Z","timestamp":1762980325573,"version":"3.41.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.mehy.2016.10.007","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T21:34:14Z","timestamp":1476912854000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Modified platelet-rich plasma with transforming growth factor \u03b21 neutralization antibody injection may reduce recurrence rate of urethral stricture"],"prefix":"10.1016","volume":"97","author":[{"given":"Murat","family":"Gul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2016.10.007_b0005","unstructured":"Jordan GH, McCammonn KA. Surgery of the penis andurethra. Campbell-Walsh Urology. \u2013, 10th ed.\/editor-in-chief, Alan J. Wein; editors, Louis R. Kavoussi et al., Saunders; 2012. p. 967\u2013983."},{"key":"10.1016\/j.mehy.2016.10.007_b0010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0022-5347(17)35879-2","article-title":"Newly diagnosed bulbar urethral strictures: etiology and outcome of various treatments","volume":"150","author":"Stormont","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.mehy.2016.10.007_b0015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ncpuro0320","article-title":"What is the place of internal urethrotomy in the treatment of urethral stricture disease?","volume":"2","author":"Naude","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.mehy.2016.10.007_b0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/089277901753205906","article-title":"Intra urethral brachytherapy for prevention of recurrent urethral stricture after internal urethrotomy or transurethral resection of scar","volume":"15","author":"Sun","year":"2001","journal-title":"J Endourol"},{"issue":"4","key":"10.1016\/j.mehy.2016.10.007_b0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-5347(18)30303-3","article-title":"Effects of DVIU and colchicine combination therapy on recurrent anterior urethral strictures [abstract 38]","volume":"177","author":"Carney","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.mehy.2016.10.007_b0030","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.eururo.2006.11.038","article-title":"Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy","volume":"51","author":"Mazdak","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.mehy.2016.10.007_b0035","first-page":"132","article-title":"Triamcinolone injection following internal urethrotomy for treatment of urethral stricture","volume":"8","author":"Tavakkoli","year":"2011","journal-title":"Urol J"},{"key":"10.1016\/j.mehy.2016.10.007_b0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1442-2042.2007.01693.x","article-title":"Effect of intra urethral captopril gel on the recurrence of urethral stricture after direct vision internal urethrotomy: phase II clinical trial","volume":"14","author":"Shirazi","year":"2007","journal-title":"Int J Urol"},{"year":"2005","series-title":"Dental and cranio facial applications of platelet-rich plasma","author":"Marx","key":"10.1016\/j.mehy.2016.10.007_b0045"},{"key":"10.1016\/j.mehy.2016.10.007_b0050","unstructured":"Harmon K, Hanson R, Bowen J, et al. Platelet Rich Plasma (PRP) Guidelines. International Cellular Medicine Society; 2011. p1\u201317."},{"key":"10.1016\/j.mehy.2016.10.007_b0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biomaterials.2016.02.017","article-title":"Customized platelet-rich plasma with transforming growth factor \u03b21 neutralization antibody to reduce fibrosis in skeletal muscle","volume":"87","author":"Li","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.mehy.2016.10.007_b0060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2016.10.007_b0065","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/01.PRS.0000138251.07040.51","article-title":"Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing","volume":"114","author":"Eppley","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.mehy.2016.10.007_b0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/JSA.0b013e3182999712","article-title":"The basic science of platelet-richplasma (PRP): what clinicians need to know?","volume":"21","author":"Arnoczky","year":"2013","journal-title":"Sports Med Arthrosc"},{"key":"10.1016\/j.mehy.2016.10.007_b0075","doi-asserted-by":"crossref","first-page":"21922","DOI":"10.1186\/ar3914","article-title":"Platelet-richplasma therapy \u2013 future or trend?","volume":"14","author":"Dhillon","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.mehy.2016.10.007_b0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12178-008-9032-5","article-title":"Platelet rich plasma injection grafts for musculoskeletal injuries: a review","volume":"1","author":"Sampson","year":"2008","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"5","key":"10.1016\/j.mehy.2016.10.007_b0085","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5999\/aps.2013.40.5.530","article-title":"Platelet-rich plasma: quantitative assessment of growth factor levels and 11 comparative analysis of activated and inactivated groups","volume":"40","author":"Lee","year":"2013","journal-title":"Arch Plast Surg"},{"key":"10.1016\/j.mehy.2016.10.007_b0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","article-title":"Regulation of wound healing by growth factors and cytokines","volume":"83","author":"Werner","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2016.10.007_b0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1051\/ject\/200638174","article-title":"Platelet-rich plasma and platelet gel: a review","volume":"38","author":"Everts","year":"2006","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.mehy.2016.10.007_b0100","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1902\/jop.2010.090637","article-title":"Short implants in maxillae and mandibles: a retrospective study with 1 to 8years of follow-up","volume":"81","author":"Anitua","year":"2010","journal-title":"J Periodontol"},{"key":"10.1016\/j.mehy.2016.10.007_b0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1600-051X.2008.01248.x","article-title":"5-year clinical experience with BTI dental implants: risk factors for implant failure","volume":"35","author":"Anitua","year":"2008","journal-title":"J Clin Periodontol"},{"issue":"6958","key":"10.1016\/j.mehy.2016.10.007_b0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"2-4","key":"10.1016\/j.mehy.2016.10.007_b0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/08830189509056711","article-title":"Regulation of type I collagen genes expression","volume":"12","author":"Karsenty","year":"1995","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.mehy.2016.10.007_b0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.0022-202x.2001.01690.x","article-title":"Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming growth-factor-beta-mediated Smad3 activation in fibroblasts","volume":"118","author":"McGaha","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2016.10.007_b0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00000658-199508000-00006","article-title":"Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair","volume":"222","author":"Lin","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.mehy.2016.10.007_b0130","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1096\/fasebj.13.13.1774","article-title":"Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP","volume":"13","author":"Duncan","year":"1999","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.mehy.2016.10.007_b0135","doi-asserted-by":"crossref","first-page":"e0117302","DOI":"10.1371\/journal.pone.0117302","article-title":"Platelet-rich plasma, especially when combined with a TGF-\u03b2 inhibitor promotes proliferation, viability and myogenic differentiation of myoblasts in vitro","volume":"10","author":"Kelc","year":"2015","journal-title":"PLoS One"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716304911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716304911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:52:58Z","timestamp":1749664378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716304911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":27,"alternative-id":["S0306987716304911"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.10.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified platelet-rich plasma with transforming growth factor \u03b21 neutralization antibody injection may reduce recurrence rate of urethral stricture","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}